HomeSLS • NASDAQ
add
Sellas Life Sciences Group Inc
Previous close
$1.34
Day range
$1.36 - $1.47
Year range
$0.77 - $1.84
Market cap
132.37M USD
Avg Volume
1.08M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.02M | -1.94% |
Net income | -6.74M | 17.20% |
Net profit margin | — | — |
Earnings per share | -0.08 | 68.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.89M | 448.85% |
Total assets | 19.43M | 212.46% |
Total liabilities | 9.97M | -29.79% |
Total equity | 9.46M | — |
Shares outstanding | 90.85M | — |
Price to book | 10.31 | — |
Return on assets | -87.27% | — |
Return on capital | -148.85% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.74M | 17.20% |
Cash from operations | -7.15M | -48.25% |
Cash from investing | — | — |
Cash from financing | 8.00K | -99.76% |
Net change in cash | -7.14M | -396.53% |
Free cash flow | -5.15M | -157.10% |
About
Founded
2006
Website
Employees
15
